Thérapie par sélénite de sodium chez le patient aux soins intensifs: supplémentation ou intervention pharmacologique ?

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Réanimation

• Publication date

  2013-09-09

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/S13546-013-0717-4
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mitochondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis

  2013cited by this paper
• Effect of Parenteral Selenium Supplementation in Critically Ill Patients: A Systematic Review and Meta-Analysis

  2013influential reference
• The effect of selenium therapy on mortality in patients with sepsis syndrome: simple selenium supplementation or real (5 H2O)·Na2SeO3 pharmacological effect?*.

  2013influential reference
• Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012

  2013cited by this paper
• The Effect of Selenium Therapy on Mortality in Patients With Sepsis Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials*

  2013influential reference
• Pharmaconutrition with antioxidant micronutrients in the critically ill: the time has come!

  2013cited by this paper
• A randomized trial of glutamine and antioxidants in critically ill patients.

  2013cited by this paper
• Pharmaconutrition with arginine decreases bacterial translocation in an animal model of severe trauma. Is a clinical studied justified? .... The time is now!

  2012cited by this paper
• Selenium supplementation in the critically ill.

  2012influential reference
• Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis

  2012influential reference
• Selenium in Human Health and Disease

  2011cited by this paper
• The intraoperative decrease of selenium is associated with the postoperative development of multiorgan dysfunction in cardiac surgical patients*

  2011cited by this paper
• Oxidative stress and mitochondrial dysfunction in sepsis.

  2011cited by this paper
• High-dose selenium substitution in sepsis: a prospective randomized clinical trial

  2011influential reference
• Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients

  2011influential reference
• High-dose selenium reduces ventilator-associated pneumonia and illness severity in critically ill patients with systemic inflammation

  2011influential reference
• [Micronutrients: myths and realities].

  2011cited by this paper
• High-dose selenium for critically ill patients with systemic inflammation: pharmacokinetics and pharmacodynamics of selenious acid: a pilot study.

  2010cited by this paper
• Methods of assessment of iodine status in humans: a systematic review.

  2009cited by this paper
• A LARGE-BOLUS INJECTION, BUT NOT CONTINUOUS INFUSION OF SODIUM SELENITE IMPROVES OUTCOME IN PERITONITIS

  2009influential reference
• Selenoprotein P, Rather than Glutathione Peroxidase, as a Potential Marker of Septic Shock and Related Syndromes

  2009cited by this paper
• Methods of assessment of selenium status in humans: a systematic review.

  2009cited by this paper
• Serum selenium and glutathione peroxidase-3 activity: biomarkers of systemic inflammation in the critically ill?

  2009cited by this paper
• Selenium supplementation in the critically ill: posology and pharmacokinetics

  2009cited by this paper
• Impact of high-dose antioxidants on outcomes in acutely injured patients.

  2008cited by this paper
• Critically elucidating the role of selenium

  2008influential reference
• Selenocompounds and Selenium: A Biochemical Approach to Sepsis

  2008influential reference
• Monitoring the clinical introduction of a glutamine and antioxidant solution in critically ill trauma and burn patients.

  2008cited by this paper
• Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients

  2008cited by this paper
• Cancer chemoprevention: a radical perspective.

  2008cited by this paper
• Antioxidant supplementation in sepsis and systemic inflammatory response syndrome

  2007cited by this paper
• Effect of selenium supplementation on biochemical markers and outcome in critically ill patients.

  2007influential reference
• Optimizing the dose of glutamine dipeptides and antioxidants in critically ill patients: a phase I dose-finding study.

  2007cited by this paper
• Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study

  2007cited by this paper
• From Selenium to Selenoproteins: Synthesis, Identity, and Their Role in Human Health

  2007cited by this paper
• Selenium in Intensive Care (SIC): Results of a prospective randomized, placebo‐controlled, multiple‐center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock*

  2007influential reference
• Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure.

  2007cited by this paper
• Selenoproteins and their impact on human health through diverse physiological pathways.

  2006cited by this paper
• Seleno-enzymes and seleno-compounds: the two faces of selenium

  2006cited by this paper
• Update on clinical micronutrient supplementation studies in the critically ill

  2006cited by this paper
• Reduction of nosocomial pneumonia after major burns by trace element supplementation: aggregation of two randomised trials

  2006cited by this paper
• Selenium in critical illness

  2006cited by this paper
• ESPEN Guidelines on Parenteral Nutrition: intensive care.

  2006cited by this paper
• Selenite-induced apoptosis of osteoclasts mediated by the mitochondrial pathway.

  2006cited by this paper
• Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis.

  2005cited by this paper
• Selenium substitution has no direct effect on thyroid hormone metabolism in critically ill patients.

  2004cited by this paper
• Distribution of selenium-containing proteins in human serum

  2004cited by this paper
• Selenium: the Se-XY nutraceutical.

  2004cited by this paper
• The epidemiology of sepsis in the United States from 1979 through 2000.

  2003cited by this paper
• Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome

  2003cited by this paper
• Current epidemiology of septic shock: the CUB-Réa Network.

  2003cited by this paper
• Selenium regulates transcription factor NF-kappaB activation during the acute phase reaction.

  2003cited by this paper
• Association between mitochondrial dysfunction and severity and outcome of septic shock.

  2002cited by this paper
• Oxidative stress in critically ill patients with systemic inflammatory response syndrome

  2002cited by this paper
• Protection of Mice from Allergen-induced Asthma by Selenite

  2002cited by this paper
• The importance of selenium to human health.

  2000cited by this paper
• Selenium and human health.

  2000cited by this paper
• Selenoprotein P: properties, functions, and regulation.

  2000cited by this paper
• Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis.

  1999cited by this paper
• Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome.

  1999cited by this paper
• Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients.

  1998cited by this paper
• Distribution of selenium in human blood plasma and serum.

  1996cited by this paper
• Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction.

  1995cited by this paper
• Further observations on the human maximum safe dietary selenium intake in a seleniferous area of China.

  1994cited by this paper
• Selenium Toxicity in Animals with Emphasis on Man

  1986influential reference

• No citing papers are available for this paper.